Review article · 2024 · Open access
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
npj Precision Oncology, 8(1), 31 · Published 10 February 2024 · DOI 10.1038/s41698-024-00522-z
In brief
“Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance” is a 2024 review article by Shujing Wang and 6 co-authors, published in npj Precision Oncology. OpenAlex counts 679 citations as of 15 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at npj Precision Oncology.
- Citations
- 679
- Most cited in
- 2025 (293)
- Field-weighted impact
- 24.72
- References
- 207
- Authors
- 7
Abstract
Tumor drug resistance emerges from the interaction of two critical factors: tumor cellular heterogeneity and the immunosuppressive nature of the tumor microenvironment (TME). Tumor-associated macrophages (TAMs) constitute essential components of the TME. M2-like TAMs are essential in facilitating tumor metastasis as well as augmenting the drug resistance of tumors. This review encapsulates the mechanisms that M2-like TAMs use to promote tumor drug resistance. We also describe the emerging therapeutic strategies that are currently targeting M2-like TAMs in combination with other antitumor drugs, with some still undergoing clinical trial evaluation. Furthermore, we summarize and analyze various existing approaches for developing novel drugs that target M2-like TAMs to overcome tumor resistance, highlighting how targeting M2-like TAMs can effectively stop tumor growth, metastasis, and overcome tumor drug resistance.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wang, S., Wang, J., Chen, Z., Luo, J., Guo, W., Sun, L., & Lin, L. (2024). Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. npj Precision Oncology, 8(1), 31. https://doi.org/10.1038/s41698-024-00522-z
MLA 9
Wang, Shujing, et al. “Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance.” npj Precision Oncology, vol. 8, no. 1, 2024, p. 31. https://doi.org/10.1038/s41698-024-00522-z.
Chicago
Wang, Shujing, Jingrui Wang, Zhiqiang Chen, Jiamin Luo, Wei Guo, Lingling Sun, and Lizhu Lin. 2024. “Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance.” npj Precision Oncology 8 (1): 31. https://doi.org/10.1038/s41698-024-00522-z.
Harvard
Wang, S. et al. (2024) ‘Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance’, npj Precision Oncology, 8(1), p. 31. doi:10.1038/s41698-024-00522-z.
IEEE
S. Wang et al., “Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance,” npj Precision Oncology, vol. 8, no. 1, p. 31, 2024, doi: 10.1038/s41698-024-00522-z.
BibTeX
@article{wang2024targeting,
title = {{Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance}},
author = {Wang, Shujing and Wang, Jingrui and Chen, Zhiqiang and Luo, Jiamin and Guo, Wei and Sun, Lingling and Lin, Lizhu},
journal = {npj Precision Oncology},
year = {2024},
volume = {8},
number = {1},
pages = {31},
doi = {10.1038/s41698-024-00522-z},
url = {https://doi.org/10.1038/s41698-024-00522-z}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 94 | |
| 2025 | 293 | |
| 2026 | 292 |
Its field-weighted citation impact is 24.72: it has been cited 24.72 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- M2-like tumor-associated macrophages
- chemoresistance
- tumor microenvironment
- tumor immunosuppression
- metastasis
- TAM repolarization
- combination therapy
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Wang, S., Wang, J., Chen, Z., Luo, J., Guo, W., Sun, L., & Lin, L. (2024). Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. npj Precision Oncology, 8(1), 31. https://doi.org/10.1038/s41698-024-00522-z
How many times has this paper been cited?
679 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at npj Precision Oncology.
Who wrote this paper?
Shujing Wang, Jingrui Wang, Zhiqiang Chen, Jiamin Luo, Wei Guo, Lingling Sun, Lizhu Lin.
What is the DOI of this paper?
10.1038/s41698-024-00522-z. The permanent link is https://doi.org/10.1038/s41698-024-00522-z.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.